Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.78%84 ROA % is 17.48% as of Mar. 2026, which is 33% below its 10-year median of 25.95. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Prevest Denpro ranks better than 95.56% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Prevest Denpro's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹232.9 Mil.
Prevest Denpro's average Total Assets over the quarter that ended in Mar. 2026 was ₹1,331.9 Mil. Therefore, Prevest Denpro's annualized ROA % for the quarter that ended in Mar. 2026 was 17.48%.
The historical rank and industry rank for Prevest Denpro's ROA % or its related term are showing as below:
BOM:543363'
s ROA % Range Over the Past 10 Years
Min: 16.67 Med: 25.95 Max: 43.91
Current: 16.67
During the past 8 years, Prevest Denpro's highest ROA % was 43.91%. The lowest was 16.67%. And the median was 25.95%.
BOM:543363's ROA % is ranked better than 95.56% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs BOM:543363: 16.67
Prevest Denpro (BOM:543363) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Prevest Denpro ROA % Related Terms
Prevest Denpro ROA % Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Prevest Denpro's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's ROA % distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Prevest Denpro (BOM:543363) has a ROA % of 17.48% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Prevest Denpro and its competitors. This is 33% below median its historical median of 25.95. Over the past decade, Prevest Denpro's ROA % has ranged from 16.67 to 43.91. According to the industry distribution chart, Prevest Denpro ranks #38 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 4.4%.
Is Prevest Denpro's ROA % too high?
Prevest Denpro's current ROA % of 17.48% is 33% below median its 10-year median of 25.95. Over the past 10 years, this metric has ranged from a low of 16.67 to a high of 43.91. The Medical Devices & Instruments industry median ROA % is 0.56. Prevest Denpro's value of 17.48% is 3021.4% above this industry median. Based on the distribution chart, Prevest Denpro ranks #38 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #38 out of 855 companies for ROA %. This places Prevest Denpro in the top 4% of its industry — outperforming the majority of peers. The industry median ROA % is 0.56. Prevest Denpro's value of 17.48% is 3021.4% above this benchmark. Historically, Prevest Denpro's own ROA % has ranged from 16.67 to 43.91 over the past decade. While the company's 10-year median is 25.95 vs. the industry median of 0.56, Prevest Denpro has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current ROA % of 17.48% is 3021.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current ROA % is 17.48%, which is 33% below median its own 10-year median of 25.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current ROA % is 17.48%, which is 33% below median its 10-year median of 25.95 and 3021.4% above the Medical Devices & Instruments industry median of 0.56. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current ROA % is 17.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
ROA %: 17.48% (33% below median its 10-year median of 25.95)
GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
Industry Position: 3021.4% above the Medical Devices & Instruments median (#38 of 855)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score
Get the complete analysis for BOM:543363
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
